Share Midodrine hydrochloride, the low blood pressure medicine, must be taken off the United State market for the reason that it required post-approval researches to confirm the medical advantage of the drug have not been completed, says the Food and Drug Administration. The medicine, promoted under the brand name ProAmatine by Shire Development Inc. and [...] [...more]
Share A latest contraceptive is put to strike the US market after the Food and Drug Administration (FDA) said it had specified its stick of endorsement to an ‘emergency pill’ that might be in use up to five days behind having defenseless sex. The contraceptive named Ella was approved after performing the concluding clinical examinations [...] [...more]
Share How do doctors think regarding teens who wish for the weight loss process? Today, Lap-Band surgery is becoming increasingly common. Louis Garcia, with 347 pounds, 17 years old, had a blood pressure that read 180 over 100. His health was weakening quickly. His pediatrician recommended he must get the Lap-Band, a method that tautens [...] [...more]
Share The U.S. FDA announced that patients taking care of with Cubicin, an intravenous antibiotic, sprint an augmented threat of rising eosinophilic pneumonia, a uncommon and potentially life-threatening situation. Cubicin is the trade name for the generic medicine daptomycin. The medicine was first permitted in 2003 for taking care of severe skin infections and in [...] [...more]
Share Long ago, the only way to eliminate horrid varicose veins is the vein stripping. This technique included making an opening in the leg, and using a hooked wire to draw the exaggerated vein out of the body. The invasiveness of vein stripping frequently answered in an all-night hospital stay and extensive limit of physical [...] [...more]
Share The benefit of using the top-selling cancer drug Avastin for breast cancer was questioned by the Food and Drug Administration. The improvement visible in women given chemotherapy alone and those given with chemotherapy and Avastin is not clinically significant, the agency said. They added that there were more critical side effects, such as bleeding, [...] [...more]
Share In Nasdaq, trading shares of Vivus Inc. rose after an authoritarian review of its weight-loss pill Onexa was not as burdensome as many investors expected. Manufacturers of rival treatments also saw their stock rise. A mixture of the appetite suppressant phentermine and the anticonvulsant topirimate, is the Vivus Onexa that may basis birth deficiencies [...] [...more]
|
|
